Article
Population structure and pharmacogenomic risk stratification in the United States.
BMC biology - 13 Oct 2020
Nagar Shashwat Deepali, Conley Andrew B, Jordan I King
Abstract excerpt
BACKGROUND: Pharmacogenomic (PGx) variants mediate how individuals respond to medication, and response differences among racial/ethnic groups have been attributed to patterns of PGx diversity. We hypothesized that genetic ancestry (GA) would provide higher resolution for stratifying PGx risk, since it serves as a more reliable surrogate for genetic diversity than self-identified race/ethnicity (SIRE), which...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
